Non-invasive vascular imaging: Assessing tumour vascularity

European Radiology

Volumn 8, Issue 4, 1998, Pages 517-527

  Delorme, S ^a   Knopp, M V ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Angiography; Contrast agents; Doppler; MRI; Tumour vascularity; US

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM;

ANGIOGRAPHY; BLOOD FLOW; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION AND FORECASTING; REVIEW; SENSITIVITY AND SPECIFICITY; VASCULARIZATION;

ANGIOGRAPHY; ANTINEOPLASTIC AGENTS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0031636875     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300050428     Document Type: Review

References (86)

1. Folkman J (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol 3: 65-71
2. Vaupel P (1994) Blood flow, ogygenation, tissue pH distribution, and bioenergetic status of tumors. Ernst Schering Research Foundation, Berlin
3. Less JR, Skalak TC, Sevick EM, Jain RK (1991) Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 51: 265-273
4. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039
5. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31
6. Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Werb Z, Banda MJ (1983) Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221: 1283-1285
7. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584
8. Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J (1994) Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344: 82-86
9. O'Reilly MS, Holmgren L, Chen C, Folkman J (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2: 689-692
10. Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Mezzetti M, Testolin A, Bevilacqua P (1993) Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 55: 739-744
11. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F (1994) Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466
12. Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM, Carroll PR (1995) Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol 154: 69-71
13. Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI (1994) Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol Head Neck Surg 111: 417-422
14. Roychowdhury DF, Tseng A Jr, Fu KK, Weinburg V, Weidner N (1996) New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression. Cancer 77: 1419-1426
15. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887
16. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409
17. Weidner N (1993) Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 10: 302-313
18. Weidner N, Gasparini G (1994) Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients. Breast Cancer Res Treat 29: 97-107
19. Weidner N (1995) Prognostic factors in breast carcinoma. Curr Opin Obstet Gynecol 7: 4-9
20. Weidner N, Folkman J (1996) Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol 167-190
21. Baker DG, Krochak RJ (1989) The response of the microvascular system to radiation: a review. Cancer Invest 7: 287-294
22. Narayan K, Spiropoulos A (1990) The radioresponsiveness of normal and tumour microvasculature. Australas Radiol 34: 312-316
23. Zywietz F (1990) Vascular and cellular damage in a murine tumour during fractionated treatment with radiation and hyperthermia. Strahlenther Onkol 166: 493-501
24. Dimitrievich GS, Fischer Dzoga K, Griem ML (1984) Radiosensitivity of vascular tissue. I. Differential radiosensitivity of capillaries: a quantitative in vivo study. Radiat Res 99: 511-535
25. Denekamp J (1993) Limited role of vasculature-mediated injury in tumor response to radiotherapy. J Natl Cancer Inst 85: 935-937
26. Budach W, Taghian A, Freeman J, Gioioso D, Suit HD (1993) Impact of stromal sensitivity on radiation response of tumors. J Natl Cancer Inst 85: 988-993
27. Schoenberger SG, Sutherland CM, Robinson AE (1988) Breast neoplasms: duplex sonographic imaging as an adjunct in diagnosis. Radiology 168: 665-668
28. Burns PN, Halliwell M, Wells PNT, Webb AJ (1982) Ultrasonic Doppler studies of the breast. Ultrasound Med Biol 8: 127-143
29. Cosgrove DO, Kedar RP, Bamber JC, Al-Murrani B, Davey JBN, Fisher C, McKinna JA, Svensson WE, Tohno E, Vagios E, Alsanjari NA (1993) Breast diseases: Color Doppler US in differential diagnosis. Radiology 189: 99-104
30. Cosgrove DO, Bamber JC, Davey JB, McKinna JA, Sinnet HD (1990) Color Doppler signals from breast tumors. Radiology 176: 175-180
31. Delorme S, Huber S, Albert B, Lohr F, Knopp MV, Junkermann H, van Kaick G (1995) Farbdopplersonographie bei Mammatumoren: Quantifizierung durch computergestützte Verfahren. Tumordiagn Ther 16: 180-186
32. Huber S, Delorme S, Knopp MV, Junkermann H, Zuna I, Fournier D von, van Kaick G (1994) Breast tumors: computer-assisted quantitative assessment with color Doppler US. Radiology 192: 797-801
33. Kedar RP, Cosgrove DO, Bamber JC, Bell DS (1995) Automated quantification of color Doppler signals: a preliminary study in breast tumors. Radiology 197: 39-43
34. Madjar H, Sauerbrei W, Prompeler HJ, Wolfarth R, Gutter H (1997) Color Doppler and duplex flow analysis for classification of breast lesions. Gynecol Oncol 64: 392-403
35. Madjar H, Prömpeler H, Sauerbrei W, Wolfarth R, Pfleiderer A (1994) Color Doppler flow criteria of breast lesions. Ultrasound Med Biol 20: 849-858
36. Raza S, Baum JK (1997) Solid breast lesions: evaluation with power Doppler US. Radiology 203: 164-168
37. Sahin Akyar G, Sumer H (1996) Color Doppler ultrasound and spectral analysis of tumor vessels in the differential diagnosis of solid breast masses. Invest Radiol 31: 72-79
38. Madjar H, Münch S, Sauerbrei W, Bauer M, Schillinger H (1990) Differenzierte Mammadiagnostik durch CW-Doppler-Ultraschall. Radiologe 30: 193-197
39. Srivastava A, Webster DJT, Woodcock JP, Shrotria S, Mansel RE, Hughes LE (1988) Role of Doppler ultrasound flowmetry in the diagnosis of breast lumps. Br J Surg 75: 851-853
40. Delorme S, Weisser G, Zuna I, Fein M, Lorenz A, Lorenz WJ, van Kaick G (1995) Quantitative characterization of color Doppler images: reproducibility, accuracy and limitations. J Clin Ultrasound 23: 537-550
41. Fein M, Delorme S, Weisser G, Zuna I, van Kaick G (1995) Quantification of color Doppler for the evaluation of tissue vascularisation. Ultrasound Med Biol 21: 1013-1019
42. Bell DS, Bamber JC, Eckersley RJ (1995) Segmentation and analysis of colour Doppler images of tumour vasculature. Ultrasound Med Biol 21: 635-647
43. Sohn C, Stolz W, Grischke EM, Wallwiener D, Bastert G, Fournier D von (1992) Die dopplersonographische Untersuchung von Mammatumoren mit Hilfe der Farbdopplersonographie, der Duplexsonographie und des CW-Dopplers. Zentralbl Gynäkol 114: 249-253
44. Sohn C, Grischke EM, Wallwiener D, Kaufmann M, Fournier D von, Bastert G (1992) Die sonographische Durchblutungsdiagnostik gut- und bösartiger Brusttumoren. Geburtshilfe Frauenheilkd 52: 397-403
45. Konishi Y, Hamada M, Shimada K, Okuno T, Hasimoto T, Kajiwara T (1993) Doppler spectral analysis of the intratumoral waveform in breast diseases. Imaging 60 (Suppl 2): 18 (Abstract)
46. Steinkamp HJ, Maurer J, Cornehl M, Knobber D, Hettwer H, Felix R (1994) Recurrent cervical lymphadenopathy: differential diagnosis with color-duplex sonography. Eur Arch Otorhinolaryngol 251: 404-409
47. Steinkamp HJ, Rausch M, Maurer J, Hosten N, Schedel H, Langer R, Felix R (1994) Farbkodierte Duplexsonographie in der Differentialdiagnostik zervikaler Lymphknotenvergrösserungen. Fortschr Röntgenstr 161: 226-232
48. Tschammler A, Gunzer U, Reinhart E, Höhmann D, Feller AC, Müller W, Lackner K (1991) Dignitätsbeurteilung vergrößerter Lymphknoten durch qualitative und semiquantitative Auswertung der Lymphknotenperfusion mit der farbkodierten Duplexsonographie. Fortschr Röntgenstr 154: 414-418
49. Kedar RP, Cosgrove DO, Smith IE, Mansi JL, Bamber JC (1994) Breast carcinoma: measurement of tumor response to primary medical therapy with color Doppler flow imaging. Radiology 190: 825-830
50. Sohn C, Bastert G (1995) Die Ultraschall-Blutflussmessung in malignen Tumoren ist ein möglicher, neuer Prognosefaktor. Gynäkol Geburtshilfliche Rundsch 35 (Suppl 1): 98-102
51. Delorme S, Dietz A, Rudat V, Zuna I, Bahner ML, van Kaick G (1997) Prognostic significance of colour Doppler findings in head and neck tumours. Ultrasound Med Biol 23: 1311-1317
52. Prince MR, Narasimham DL, Stanley JC, Chenevert TL, Williams DM, Marx MV, Cho KJ (1995) Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 197: 785-792 (Abstract)
53. Griebel J, Mayr NA, Vries A de, Knopp MV, Gneiting T, Kremser C, Essig M, Hawighorst H, Lukas PH, Yuh WT (1997) Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J Magn Reson Imaging 7: 111-119
54. Goldfarb JW, Prasad PV, Li W, Edelman RR (1997) Dynamic contrast-enhanced breath-hold 3D magnetic resonance abdominal angiography and renal perfusion. Proc ISMRM 1: 200 (Abstract)
55. Schoenberg SO, Knopp MV, Bock M, Kallinowski F, Just A, Essig M, Hawighorst H, Schad L, van Kaick G (1997) Renal artery stenosis: grading of hemodynamic changes with cine phase-contrast MR blood flow measurements. Radiology 203: 45-53
56. Schoenberg SO, Just A, Bock M, Knopp MV, Persson PB, Kirchheim HR (1997) Noninvasive analysis of renal artery blood flow dynamics with MR cine phase-contrast flow measurements. Am J Physiol 272: H2477-H2484 (Abstract)
57. Knopp MV, Hoffmann U, Brix G, Hawighorst H, Junkermann H, van Kaick G (1995) Schnelle MR-Kontrastmitteldynamik zur Charakterisierung von Tumoren. Radiologe 35: 964-972
58. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ (1995) Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 33: 506-514
59. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ (1994) Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193: 637-641
60. Knopp MV, Essig M, Wenz F, Hawighorst H, Brix G, Schad L, Bachert P, van Kaick G (1997) Functional neuroimaging in the assessment of CNS neoplasms. Eur Radiol 7 (Suppl 5): S209-S215
61. Knopp MV, Bischoff H, Geissler C, Körner M, Schoenberg SO, Hawighorst H, Schad LR, van Kaick G (1997) Fast and ultrafast contrast enhanced imaging of lung tumours. Eur Radiol S138 (Abstract)
62. Knopp MV, Sinn P, Mattern J, Weiss E, Junkermann HJ, Hawighorst H, Brix G, van Kaick G (1997) Fast dynamic MR images of gadolinium enhancements for the characterization of lesions: a radiologic/histologic analysis. Eur Radiol 7: S242 (Abstract)
63. Hawighorst H, Engenhart R, Knopp MV, Brix G, Grandy M, Essig M, Miltner P, Zuna I, Fuss M, van Kaick G (1997) Intracranial meningiomas: time- and dose-dependent effects of irradiation on tumor microcirculation by dynamic MR imaging. Magn Reson Med 15: 423-432
64. Hawighorst H, Knapstein PG, Schaeffer U, Knopp MV, Brix G, Hoffmann U, Zuna I, Essig M, van Kaick G (1996) Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. Am J Roentgenol 166: 401-408
65. Fuss M, Wenz F, Rempp K, Essig M, Lohr F, Debus J, Engenhart R, Knopp MV, Brix G, Wannenmacher M (1996) CBV maps of low-grade astrocytomas. ISMRM, book of abstracts 606 (Abstract)
66. Knopp MV, Brix G, Junkermann HJ, Sinn HP (1994) MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin North Am 2: 633-658
67. Knopp MV, Junkermann HJ, Sinn P, Hess T, Bauer S, Hawighorst H, Essig M, Marz J, Weinmann S, Fournier D, van Kaick G (1997) Therapy monitoring of neoadjuvant chemotherapy in breast cancer: potential and pitfalls. Eur Radiol 7 (Suppl 1): S242 (Abstract)
68. Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Schaeffer U, Schoenberg SO, Essig M, Vaupel P, van Kaick G (1997) Angiogenic activity of uterine cervical carcinoma: characterization by pharmacokinetic MR imaging and histologic microvessel density with correlation to lymphatic involvement. Cancer Res 57: 4777-4786
69. Burns PN (1994) Ultrasound contrast agents in radiological diagnosis. Radiol Med 87: 71-82
70. Campani R, Bozzini A, Calliada F, Bottinelli O, Anguissola R, Conti MP, Corsi G (1994) Color Doppler imaging of liver metastases. The value phase-III of a US contrast agent: SH U 508 A (Levovist) Schering: Radiol Med 87: 32-40
71. Schlief R (1991) Ultrasound contrast agents. Curr Opin Radiol 3: 198-207
72. Schürmann R, Schlief R (1994) Saccharide-based contrast agents. Characteristics and diagnostic potential. Radiol Med 87: 15-23
73. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER (1996) Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology 198: 679-686
74. Lee WJ, Chu JS, Huang CS, Chang MF, Chang KJ, Chen KM (1996) Breast cancer vascularity: color Doppler sonography and histopathology study. Breast Cancer Res Treat 37: 291-298
75. Schrope BA, Newhouse VL (1993) Second harmonic ultrasonic blood perfusion measurement. Ultrasound Med Biol 19: 567-579
76. Schrope BA, Newhouse VL, Uhlendorf V (1992) Simulated capillary blood flow measurement using a nonlinear ultrasonic contrast agent. Ultrason Imaging 14: 134-158
77. Hauff P, Fritzsch T, Reinhardt M, Weitschies W, Luders F, Uhlendorf V, Heldmann D (1997) Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Invest Radiol 32: 94-99
78. Denekamp J (1993) Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 66: 181-196
79. Passe TJ, Bluemke DA, Siegelman SS (1997) Tumor angiogenesis: tutorial on implications for imaging. Radiology 203: 593-600
80. Brem H, Folkman J (1993) Analysis of experimental antiangiogenic therapy. J Pediatr Surg 28: 445-450
81. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL (1989) Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med 320: 1197-1200
82. Myers C, Cooper M, Stein C, LaRocca R, Walther MM, Weiss G, Choyke P, Dawson N, Steinberg S, Uhrich MM et al. (1992) Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer (see comments). J Clin Oncol 10: 881-889
83. Britton PD, Coulden RA (1990) The use of duplex Doppler ultrasound in the diagnosis of breast cancer. Clin Radiol 42: 399-401
84. Dixon JM, Walsh J, Paterson D, Chetty U (1992) Colour Doppler ultrasonography studies of benign and malignant breast lesions. Br J Surg 79: 259-260
85. Delorme S, Anton HW, Knopp MV, Zuna I, Junkermann I, Fournier D von, van Kaick G (1993) Breast cancer: assessment of vascularity by color Doppler: Eur Radiol 3: 253-257
86. Huber S, Helbich T, Kettenbach J, Dock W, Zuna I, Delorme S (1998) Effects of microbubble contrast agent on breast tumors: computerassisted quantitative assessment with color Doppler US. Radiology (in press)